Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 32 a 51 di 53
Titolo Data di pubblicazione Autore(i) File
Preoperative evaluation of tumor ploidy in endometrial carcinoma - An accurate tool to identify patients at risk for extrauterine disease and recurrence 1999 T. Susini; S. Rapi; D. Massi; L. Savino; G. Amunni; G. L. Taddei; G. Massi
Primary cutaneous B-cell lymphoma: A unique type of low grade lymphoma. Clinicopathologic and immunologic study of 83 cases 1991 M. SANTUCCI; N. PIMPINELLI; L. ARGANINI
Proceedings of the Consensus Conference on the Role of the Sentinel Limph Node Biopsy in Carcinoma of the Breast,April 19-22,2001,Philadelphia ,Pennsylvania 2002 SCHWARTZ G.F.; GIULIANO A.E.; VERONESI U.; THE CONSENSUS CONFERENCE COMMITTE; L. CATALIOTTI
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 2012 Livi, L; Meattini, I; Saieva, C; Franzese, C; Di Cataldo, V; Greto, D; Franceschini, D; Scotti, V; Bonomo, P; Nori, J; Sanchez, L; Vezzosi, V; Bianchi, S; Cataliotti, L; Biti, G
Prognostic value of proliferating cell nuclear antigen in lymph node negative breast cancer patients 1993 BIANCHI S.; PAGLIERANI M.; ZAMPI G.; CARDONA G.; L. CATALIOTTI; BONARDI R.; ZAPPA M.; CIATTO S.
Prognostic value of the 131I whole-body scan in postsurgical therapy for differentiated thyroid cancer. 1983 Pupi A; Castagnoli A; Morotti A; La Cava G; Meldolesi U
Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications 2006 CALDARELLA A; CROCETTI E; C. COMIN; JANNI A; PEGNA AL; PACI E
Prostate cancer: Developing novel approaches to castration-sensitive disease 2017 Francini E.; Taplin M.-E.
Relaxin influences the growth of MCF-7 breast cancer cells. Mitogenic and antimitogenic action depends on peptide concentration. 1992 M. Bigazzi; M. L. Brandi; G. Bani; T. B. Sacchi
Relevance of biologic markers in colorectal carcinoma: A comparative study of a broad panel 2002 BAROZZI C; RAVAIOLI M; D'ERRICO A; GRAZI G; POGGIOLI G; CAVRINI G; MAZZIOTTI A; GRIGIONI WF
Risk factors for distant metastases from carcinoma of the parotid gland 1997 GALLO O.; A. FRANCHI; BOTTAI G.V.; FINI STORCHI I.; TESI G.; BODDI V.
The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group 2016 Geyer, Holly L.; Andreasson, Bjorn; Kosiorek, Heidi E.; Dueck, Amylou C.; Scherber, Robyn M.; Martin, Kari A.; Butler, Kristina A.; Harrison, Claire N.; Radia, Deepti H.; Cervantes, Francisco; Kiladjian, Jean-Jacques; Reiter, Andreas; Birgegard, Gunnar; Passamonti, Francesco; Senyak, Zhenya; Vannucchi, Alessandro M.; Paoli, Chiara; Xiao, Zhijian; Samuelsson, Jan; Mesa, Ruben A
Serum activin A and inhibin A: New clinical markers for hydatidiform mole 2002 Florio, Pasquale; Severi, Filiberto M.; Cobellis, Luigi; Danero, Secondo; Bomè, Alice; Luisi, Stefano; Petraglia, Felice
Short- and long-term effects of radiation on T-cell subsets in peripheral blood of patients with Hodgkin's disease. 1980 S.Romagnani; E.Maggi; G.Del Prete; G.Biti; P.Ponticelli; M.Ricci
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. 2001 R. GIANNICE; T. SUSINI; G. FERRANDINA; A. POERIO; PA. MARGARITI; R. CARMINATI; E. MARANA; S. MANCUSO; G. SCAMBIA
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 2007 T. SUSINI; G. AMUNNI; C. MOLINO; C. CARRIERO; S. RAPI; F. BRANCONI; M. MARCHIONNI; G. TADDEI; G. SCARSELLI
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria 2012 T.Cai; G.Malossini; R.Bartoletti
THIN CUTANEOUS MALIGNANT MELANOMAS (<= 1.5 MM): IDENTIFICATION OF RISK FACTORS INDICATIVE OF PROGRESSION 1999 D. MASSI; A. FRANCHI; L. BORGOGNONI; U.M. REALI; M. SANTUCCI.
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. 2012 Quaglino P;Pimpinelli N;Berti E;Calzavara-Pinton P;Alfonso Lombardo G;Rupoli S;Alaibac M;Bottoni U;Carbone A;Fava P;Fimiani M;Mamusa AM;Titli S;Zinzani PL;Bernengo MG;On behalf of the Gruppo Italiano Linfomi Cutanei (GILC)
TP53-altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity 2023 Shallis, Rory M; Daver, Naval G; Altman, Jessica K; Hasserjian, Robert P; Kantarjian, Hagop M; Platzbecker, Uwe; Santini, Valeria; Wei, Andrew H; Sallman, David A; Zeidan, Amer M
Mostrati risultati da 32 a 51 di 53
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile